Addex Starts a Second Phase IIb Trial of ADX10059 in GERD

Addex Starts a Phase IIb Trial of ADX10059 for Migraine Prevention

Addex Starts Phase IIb ADX10059, Proton Pump Inhibitor Combination Study in GERD Patients

GSK Reports Owning 5% of Addex

Addex Parkinson’s Product Progressing in Early Clinical Trials

GSK Reports Owning 3% of Addex

Better Tolerated Formulation of ADX10059 Reduces Acid Reflux

Disclosure of Shareholdings in Accordance with Stock Market Rules

Disclosure of Shareholdings in Accordance with Stock Market Rules

Addex Pharmaceuticals Reports First Half 2008 Financial Results, Maiden Profit